Jan-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Achieve has demonstrated a notable performance in the Arizona market, particularly within the Concentrates category. Over the months from October 2024 to January 2025, Achieve improved its ranking from 16th to 12th, indicating a positive trend in consumer preference and market penetration. This upward movement is further supported by a steady increase in sales, culminating in over $103,000 in January 2025. Such consistent advancement in ranking and sales volume underscores Achieve's growing influence and competitiveness in the Concentrates category. However, it's worth noting that Achieve did not make it into the top 30 for some categories, which could suggest areas for potential growth or strategic realignment.
In contrast, Achieve's performance in the Vapor Pens category in Arizona has been less dynamic. The brand's ranking fluctuated slightly, from 41st in October 2024 to maintaining the same position in January 2025, with a brief dip in between. This stability, albeit at a lower rank, suggests that while Achieve maintains a presence in the Vapor Pens market, there may be challenges in gaining a stronger foothold. The sales figures reflect this stagnation, with a dip in November followed by a minor recovery. This indicates potential opportunities for Achieve to innovate or enhance its offerings to capture a larger share of the Vapor Pens market in Arizona.
Competitive Landscape
In the competitive landscape of the concentrates category in Arizona, Achieve has demonstrated a notable upward trajectory in its rankings over the past few months. Starting from a rank of 16 in October 2024, Achieve improved to 12 by December 2024 and maintained this position into January 2025. This positive trend indicates a strengthening market presence, likely driven by strategic marketing efforts or product innovations. In contrast, iLava and Venom Extracts (AZ) experienced slight fluctuations, with iLava dropping from 9 to 11 before recovering to 10, and Venom Extracts moving from 10 to 13. Meanwhile, High Grade saw a dip in November but regained its footing by January. Achieve's consistent climb suggests a growing consumer preference, positioning it as a formidable competitor in this market segment.
Notable Products
In January 2025, the top-performing product for Achieve was the GDP RSO Syringe (1g) in the Concentrates category, which climbed to the number one rank with sales reaching 504 units. The Modified Sour Hash (1g) made a significant debut, securing the second position, while Guava Tangie Hash (1g) ranked third, showing a dip from its previous second position in November 2024. The Devil Driver Hash (1g) improved its standing to fourth place compared to its fifth position in October 2024. Lastly, the Holy Grail RSO Syringe (1g) entered the top five for the first time, indicating a growing interest in RSO products. Overall, the Concentrates category showed dynamic shifts in product rankings, reflecting evolving consumer preferences.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.